VB
Vincent Brichard
Senior Vice-President at GlaxoSmithKline Biologicals
Brussels Metropolitan Area
Overview
Vincent Brichard is currently serving as the Senior Vice-President at GlaxoSmithKline Biologicals in the Brussels Metropolitan Area. With a background in clinical trials and oncology, he has made significant contributions to the field through roles at prestigious institutions like Louvain University Medical Oncology Unit and Institut Curie, and has also invested in innovative biotech companies such as ImCheck Therapeutics and Egle Therapeutics.
Work Experience
Senior Vice-President
2002 - Current
Head of Immunotherapeutics Business Units (including antigen-sepcific cancer immunotherapy and other Therapeutic vaccines, e.g. against Alzheimer's, diabetes, multiple sclerosis or smoking cessation
Oncologist/Tumor immunology
2000 - 2002
oncologist
Medical Oncology Department
1998 - 2000
Medical Oncology/Tumor immunology
Education
MD
1986 - 1990